Diffusion-weighted imaging for assessment of lung cancer response to chemotherapy

Chinese Journal of Lung Cancer

Volumn 14, Issue 3, 2011, Pages 256-260

  Zhou, Rongchao ^a   Yu, Tielian ^a   Feng, Changchao ^b   Ma, Li ^a   Wang, Yan ^a   Li, Weidong ^a   Wang, Ying ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Department of Radiology   (China)

Author keywords

Apparent diffusion coefficient; Chemotherapy; Diffusion weighted imaging; Lung neoplasms

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; MICROCIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG MONITORING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 79953221890     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.03.20     Document Type: Article

References (14)

1. Higgins MJ, Ettinger DS. Chemotherapy for lung cancer: the state of the art in 2009. Expert Rev Anticancer Ther, 2009, 9(10): 1365-1378.
2. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomaker consensus and recommendations. Neoplasia, 2009, 11(2): 102-125.
3. Liu Y, Bai R, Sun H, et al. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol, 2009, 64(11): 1067-1074.
4. Cui Y, Zhang XP, Sun YS, et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology, 2008, 248(3): 894-900.
5. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 2000, 92(3): 205-216.
6. Jiang G. The current situation and prospect of lung cancer to radiotherapy in our country. Chin J Lung Cancer, 2000, 3(5): 921. [Chinese Source, 2000, 3(5): 921.]
7. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR, 2007, 188(4): 1001-1008.
8. Colagrande S, Carbone SF, Carusi LM, et al. Magnetic resonance diffusionweighted imaging: extraneurological applications. Radiol Med, 2006, 111(3): 392-419.
9. Liu H, Liu Y, Yu T, et al. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol, 2010, 20(4): 807-815.
10. Messiou C, deSouza NM. Diffusion Weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer Biomark, 2010, 6(1): 21-32.
11. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys, 2003, 56(4): 958-965.
12. Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology, 2002, 224(1): 177-183.
13. Einarsdóttir H, Karlsson M, Wejde J, et al. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol, 2004, 14(6): 959-963.
14. Hayashida Y, Yakushiji T, Awai K, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted imaging: Initial results. Eur Radiol, 2006, 16(12): 2637-2643.